Drug-shortage probes at DOJ and FTC
The exploding number of incidents of drug shortages— frequently leading to skyrocketing prices for life-saving medications—is drawing attention from the White House and US Senate....
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this contentIf you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch
